Skip Navigation
Department of Health and Human Services www.hhs.gov
 
Slide Tray
0 slides

Return to Slide Library

Slides

Add Presentation to Slide Tray Presentation:

Comparative Effectiveness of Therapies for Children With Autism Spectrum Disorders

Slide: 16 of 36

Key Question 2

Among children ages 2–12 years with ASDs, what are the modifiers of outcome for different treatments or approaches? Specifically:

KQ 2a: Is the effectiveness of the therapies reviewed affected by the frequency, duration, and intensity of the intervention?

KQ 2b: Is the effectiveness of the therapies reviewed affected by the training and/or experience of the individual providing the therapy?

KQ 2c: What characteristics, if any, of the child modify the effectiveness of the therapies reviewed?

KQ 2d: What characteristics, if any, of the family modify the effectiveness of the therapies reviewed?